Specialty Pharmacy Insights

ICD-9 to ICD-10 Conversion: What Healthcare Providers Need to Know

As of October 1, 2015, the U.S. healthcare system will undergo a significant change requiring that all healthcare providers and and all healthcare facilities start using ICD-10.  ICD-10 is the 10th revision of the International Statistical ...

Read More

[Part 2] Understanding the Appeals Process & Top Trends in Prior Authorizations

Prior authorizations ensure that our patients can get access to the medications they need while reducing administrative hassles for your practice. In our two-part blog series, we are giving you a "behind-the-scenes" look at what's new and what's ...

Read More

[Part I] Prior Authorizations: An Important Cost-Control Strategy for Payers in Light of Rising Drug Costs

A “BEHIND-THE-SCENES” LOOK AT WHAT’S NEW AND NEXT IN THE WORLD OF PRIOR AUTHORIZATIONS...AND HOW PROVIDERS AND PATIENTS CAN BETTER MANAGE THIS PROCESS. There is no doubt that prior authorizations are becoming a more important strategy for payers, ...

Read More

Protecting Your Practice from Data Breaches: What Every Physician Needs to Know About Information Security

Data breaches are in the headlines daily, and most issues are only those large enough to be newsworthy. From Target’s credit card breach in 2014, to the most recent hacking of data from millions of Anthem’s health plan members, consumers certainly ...

Read More

Patient Story: Oncology Patient Shares Her Inspiring Story

At Avella, it is both our privilege and responsibility to help improve patient health. Because of this, we are featuring the story of one of our incredible patients. As we all know, the journey through a serious disease is one for the patient, ...

Read More

Janedu: New FDA-Approved Drug to Treat Chronic Iron Overload

Novartis announced this week that the US Food and Drug Administration has approved Jadenu™ (deferasirox) tablets.  Jadenu is a new oral tablet for the treatment of chronic iron overload. Chronic iron overload can occur due to blood transfusions in ...

Read More

Avella Ranks Extremely High in Patient Satisfaction According to Third-Party Research

We are excited to announce the results of our latest patient satisfaction survey.  More than 95% of Avella’s customers rate their experience with the specialty pharmacy as “excellent” or “very good” according to third-party validated data. Avella’s ...

Read More

Avella Proud to Fulfill HARVONI™ for Hepatitis C Patients

A breakthrough treatment for hepatitis C genotype 1 is here. Avella is proud to fulfill HARVONI™ in treating hepatitis C patients. HARVONI™ is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV ...

Read More

Case Study: Significantly Improve Medication Non-Adherence with Behavioral Adherence Contracts

Medication non-adherence is a serious, widespread issue that impacts clinical outcomes and contributes to rising healthcare costs.  In fact, 20-30% of prescriptions written are never filled by patients and around half of all medications for chronic ...

Read More

Avella Recognized for 8th Consecutive Year on Inc. 5000 List

Avella has once again been designated as one of Inc. Magazine’s 5,000 fastest growing companies in America, currently listed at #1,772 nationwide with a 3-year growth rate of 234%.  Avella has been included in this select group of innovative ...

Read More